Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide versus sodium valproate for generalized tonic-clonic seizures
IRCT20220524054982N1Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in generalized tonic-clonic seizure (GTCS) comparing Lacosamide with Sodium valproate (2 arms). Primary endpoint: Control of generalized seizures. Started Nov 2022; status: completed.
02
Drugs
lacosamidevalproic acid
03
Conditions
generalized tonic-clonic seizure (GTCS)
Beyond the preview
Go deeper on IRCT20220524054982N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220524054982N1.